Search
- Jun 20, 2023
Big deals and small molecules with the CEO of Nimbus Therapeutics
Nimbus Therapeutics CEO Jeb Keiper describes his company’s programs and the future of small molecule drug development under the Inflation Re
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A